Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography. / Lebech, Anne-Mette; Gerstoft, Jan; Hesse, Birger; Petersen, Claus Leth; Kjaer, Andreas.

In: American Heart Journal, Vol. 147, No. 3, 2004, p. 482-8.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lebech, A-M, Gerstoft, J, Hesse, B, Petersen, CL & Kjaer, A 2004, 'Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography.', American Heart Journal, vol. 147, no. 3, pp. 482-8. https://doi.org/10.1016/j.ahj.2003.09.009

APA

Lebech, A-M., Gerstoft, J., Hesse, B., Petersen, C. L., & Kjaer, A. (2004). Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography. American Heart Journal, 147(3), 482-8. https://doi.org/10.1016/j.ahj.2003.09.009

Vancouver

Lebech A-M, Gerstoft J, Hesse B, Petersen CL, Kjaer A. Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography. American Heart Journal. 2004;147(3):482-8. https://doi.org/10.1016/j.ahj.2003.09.009

Author

Lebech, Anne-Mette ; Gerstoft, Jan ; Hesse, Birger ; Petersen, Claus Leth ; Kjaer, Andreas. / Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography. In: American Heart Journal. 2004 ; Vol. 147, No. 3. pp. 482-8.

Bibtex

@article{edb099f0accd11ddb538000ea68e967b,
title = "Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography.",
abstract = "BACKGROUND: Cardiac dysfunction has been reported in a substantial part of patients infected with the human immunodeficiency virus (HIV). However, most studies are from a time before the introduction of highly active antiretroviral treatment (HAART), which has significantly reduced HIV-associated morbidity and mortality rates. Accordingly, the prevalence of HIV-associated cardiac dysfunction may also have changed. The aim of the study was to establish the prevalence of right- and left-sided cardiac dysfunction in a Danish HIV population, most of whom were undergoing HAART, with radionuclide ventriculography. METHODS: Ninety-five consecutive patients with HIV infection were included. Mean HIV duration was 104 months, and 84% of the patients received HAART. All patients underwent radionuclide ventriculography, and plasma levels of atrial natriuetic peptide (ANP), brain natriuetic peptide (BNP), and endothelin-1 (ET-1) were measured. Thirty age- and sex-matched healthy volunteer subjects were included to establish reference values of radionuclide measurements of left and right ventricular ejection fraction and of left ventricular volume. RESULTS: Of 95 patients with HIV, 1 (1%) had a reduced left ventricular ejection fraction and 6 (7%) had a reduced right ventricle ejection fraction (0.35-0.42) compared with reference values from the age- and sex-matched reference population. Patients with HIV and reduced cardiac function did not differ in the duration of HIV, CD4 count, CD4 nadir, or HIV RNA load. No correlations were found between reduced cardiac function and levels of the 3 peptides measured. CONCLUSIONS: No major dysfunction of the left ventricle is present in a developed world HIV population. However, a small but significant part of this population has modestly reduced right-sided systolic function.",
author = "Anne-Mette Lebech and Jan Gerstoft and Birger Hesse and Petersen, {Claus Leth} and Andreas Kjaer",
note = "Keywords: Adult; Antiretroviral Therapy, Highly Active; Atrial Natriuretic Factor; Denmark; Developed Countries; Endothelin-1; Female; HIV Infections; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Ventriculography; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right",
year = "2004",
doi = "10.1016/j.ahj.2003.09.009",
language = "English",
volume = "147",
pages = "482--8",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - Right and left ventricular cardiac function in a developed world population with human immunodeficiency virus studied with radionuclide ventriculography.

AU - Lebech, Anne-Mette

AU - Gerstoft, Jan

AU - Hesse, Birger

AU - Petersen, Claus Leth

AU - Kjaer, Andreas

N1 - Keywords: Adult; Antiretroviral Therapy, Highly Active; Atrial Natriuretic Factor; Denmark; Developed Countries; Endothelin-1; Female; HIV Infections; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Ventriculography; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right

PY - 2004

Y1 - 2004

N2 - BACKGROUND: Cardiac dysfunction has been reported in a substantial part of patients infected with the human immunodeficiency virus (HIV). However, most studies are from a time before the introduction of highly active antiretroviral treatment (HAART), which has significantly reduced HIV-associated morbidity and mortality rates. Accordingly, the prevalence of HIV-associated cardiac dysfunction may also have changed. The aim of the study was to establish the prevalence of right- and left-sided cardiac dysfunction in a Danish HIV population, most of whom were undergoing HAART, with radionuclide ventriculography. METHODS: Ninety-five consecutive patients with HIV infection were included. Mean HIV duration was 104 months, and 84% of the patients received HAART. All patients underwent radionuclide ventriculography, and plasma levels of atrial natriuetic peptide (ANP), brain natriuetic peptide (BNP), and endothelin-1 (ET-1) were measured. Thirty age- and sex-matched healthy volunteer subjects were included to establish reference values of radionuclide measurements of left and right ventricular ejection fraction and of left ventricular volume. RESULTS: Of 95 patients with HIV, 1 (1%) had a reduced left ventricular ejection fraction and 6 (7%) had a reduced right ventricle ejection fraction (0.35-0.42) compared with reference values from the age- and sex-matched reference population. Patients with HIV and reduced cardiac function did not differ in the duration of HIV, CD4 count, CD4 nadir, or HIV RNA load. No correlations were found between reduced cardiac function and levels of the 3 peptides measured. CONCLUSIONS: No major dysfunction of the left ventricle is present in a developed world HIV population. However, a small but significant part of this population has modestly reduced right-sided systolic function.

AB - BACKGROUND: Cardiac dysfunction has been reported in a substantial part of patients infected with the human immunodeficiency virus (HIV). However, most studies are from a time before the introduction of highly active antiretroviral treatment (HAART), which has significantly reduced HIV-associated morbidity and mortality rates. Accordingly, the prevalence of HIV-associated cardiac dysfunction may also have changed. The aim of the study was to establish the prevalence of right- and left-sided cardiac dysfunction in a Danish HIV population, most of whom were undergoing HAART, with radionuclide ventriculography. METHODS: Ninety-five consecutive patients with HIV infection were included. Mean HIV duration was 104 months, and 84% of the patients received HAART. All patients underwent radionuclide ventriculography, and plasma levels of atrial natriuetic peptide (ANP), brain natriuetic peptide (BNP), and endothelin-1 (ET-1) were measured. Thirty age- and sex-matched healthy volunteer subjects were included to establish reference values of radionuclide measurements of left and right ventricular ejection fraction and of left ventricular volume. RESULTS: Of 95 patients with HIV, 1 (1%) had a reduced left ventricular ejection fraction and 6 (7%) had a reduced right ventricle ejection fraction (0.35-0.42) compared with reference values from the age- and sex-matched reference population. Patients with HIV and reduced cardiac function did not differ in the duration of HIV, CD4 count, CD4 nadir, or HIV RNA load. No correlations were found between reduced cardiac function and levels of the 3 peptides measured. CONCLUSIONS: No major dysfunction of the left ventricle is present in a developed world HIV population. However, a small but significant part of this population has modestly reduced right-sided systolic function.

U2 - 10.1016/j.ahj.2003.09.009

DO - 10.1016/j.ahj.2003.09.009

M3 - Journal article

C2 - 14999198

VL - 147

SP - 482

EP - 488

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 3

ER -

ID: 8465042